{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:40:49Z","timestamp":1792197649986,"version":"4.4.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-78901-2","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:02:16Z","timestamp":1792173736000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ICU-acquired pneumonia beyond pathogen detection"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5834-4063","authenticated-orcid":false,"given":"Ignacio","family":"Martin-Loeches","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"78901_CR1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2217\/fmb-2023-0128","volume":"19","author":"I Martin-Loeches","year":"2024","unstructured":"Martin-Loeches, I. et al. Molecular antimicrobial susceptibility testing in sepsis. Future Microbiol 19, 61\u201372 (2024).","journal-title":"Future Microbiol"},{"key":"78901_CR2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ccm.2022.04.003","volume":"43","author":"CI Pickens","year":"2022","unstructured":"Pickens, C. I. & Wunderink, R. G. Novel and rapid diagnostics for common infections in the critically ill patient. Clin. Chest Med. 43, 401\u2013410 (2022).","journal-title":"Clin. Chest Med."},{"key":"78901_CR3","doi-asserted-by":"publisher","unstructured":"Martin-Loeches, I. Current concepts in community- and ventilator-associated lower respiratory tract infections in ICU patients. Antibiotics 9, 380 https:\/\/doi.org\/10.3390\/antibiotics9070380 (2020).","DOI":"10.3390\/antibiotics9070380"},{"key":"78901_CR4","doi-asserted-by":"publisher","unstructured":"Vallecoccia, M. S. et al. Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia? Eur. Respir. Rev. 29, 200023 https:\/\/doi.org\/10.1183\/16000617.0023-2020 (2020).","DOI":"10.1183\/16000617.0023-2020"},{"key":"78901_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41591-020-1105-z","volume":"27","author":"W Gu","year":"2021","unstructured":"Gu, W. et al. Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids. Nat. Med. 27, 115\u2013124 (2021).","journal-title":"Nat. Med."},{"key":"78901_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-71863-5","volume":"17","author":"EC Lydon","year":"2026","unstructured":"Lydon, E. C. et al. Host\u2013microbiome archetypes differentiate infection from pathogen carriage in the human lower airway. Nat. Commun. 17, 5149 (2026).","journal-title":"Nat. Commun."},{"key":"78901_CR7","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil, A. C. et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin. Infect. Dis. 63, e61\u2013e111 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"78901_CR8","doi-asserted-by":"crossref","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","volume":"50","author":"A Torres","year":"2017","unstructured":"Torres, A. et al. International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia. Eur. Respir. J. 50, 1700582 (2017).","journal-title":"Eur. Respir. J."},{"key":"78901_CR9","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jama.297.14.1583","volume":"297","author":"M Klompas","year":"2007","unstructured":"Klompas, M. Does this patient have ventilator-associated pneumonia? JAMA 297, 1583\u20131593 (2007).","journal-title":"JAMA"},{"key":"78901_CR10","doi-asserted-by":"crossref","first-page":"1807400","DOI":"10.3389\/frai.2026.1807400","volume":"9","author":"HL Qu","year":"2026","unstructured":"Qu, H. L. et al. From microscopy to antimicrobial decisions: a clinically grounded roadmap for critical care infectious diseases. Front. Artif. Intell. 9, 1807400 (2026).","journal-title":"Front. Artif. Intell."},{"key":"78901_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2410-0","volume":"23","author":"S Keane","year":"2019","unstructured":"Keane, S. & Martin-Loeches, I. Host-pathogen interaction during mechanical ventilation: systemic or compartmentalized response? Crit. Care 23, 134 (2019).","journal-title":"Crit. Care"},{"key":"78901_CR12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jhin.2024.03.019","volume":"151","author":"A Livesey","year":"2024","unstructured":"Livesey, A. et al. Practices to prevent non-ventilator hospital-acquired pneumonia: a narrative review. J. Hosp. Infect. 151, 201\u2013212 (2024).","journal-title":"J. Hosp. Infect."},{"key":"78901_CR13","first-page":"347","volume":"24","author":"I Martin-Loeches","year":"2018","unstructured":"Martin-Loeches, I., Rodriguez, A. H. & Torres, A. New guidelines for hospital-acquired pneumonia\/ventilator-associated pneumonia: USA vs. Europe. Curr. Opin. Crit. Care 24, 347\u2013352 (2018).","journal-title":"Curr. Opin. Crit. Care"},{"key":"78901_CR14","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1007\/s00134-023-07210-9","volume":"49","author":"I Martin-Loeches","year":"2023","unstructured":"Martin-Loeches, I. et al. European Network for ICU-Related Respiratory Infections (ENIRRIs): a multinational, prospective, cohort study of nosocomial LRTI. Intensive Care Med. 49, 1212\u20131222 (2023).","journal-title":"Intensive Care Med."},{"key":"78901_CR15","doi-asserted-by":"publisher","unstructured":"Reyes, L. F. et al. Factors associated with mortality in nosocomial lower respiratory tract infections: an ENIRRI analysis. Antibiotics 14, 127 https:\/\/doi.org\/10.3390\/antibiotics14020127 (2025).","DOI":"10.3390\/antibiotics14020127"},{"key":"78901_CR16","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s00134-025-07884-3","volume":"51","author":"FP Martin","year":"2025","unstructured":"Martin, F. P. et al. Identification and validation of robust hospital-acquired pneumonia subphenotypes associated with all-cause mortality: a multi-cohort derivation and validation. Intensive Care Med 51, 692\u2013707 (2025).","journal-title":"Intensive Care Med"},{"key":"78901_CR17","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.cmi.2025.05.026","volume":"31","author":"M Colaneri","year":"2025","unstructured":"Colaneri, M. et al. Incidence, microbiology, and mortality of ventilation-associated pneumonia in a large Italian cohort of critically ill patients: results from the PROSAFE project. Clin. Microbiol. Infect. 31, 1491\u20131499 (2025).","journal-title":"Clin. Microbiol. Infect."},{"key":"78901_CR18","doi-asserted-by":"publisher","unstructured":"Bauer, P. R. et al. Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy. Eur. Respir. J. 54, 1802442 https:\/\/doi.org\/10.1183\/13993003.02442-2018 (2019).","DOI":"10.1183\/13993003.02442-2018"},{"key":"78901_CR19","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1097\/CCM.0b013e3181a037ac","volume":"37","author":"D Koulenti","year":"2009","unstructured":"Koulenti, D. et al. Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit. Care Med. 37, 2360\u20132368 (2009).","journal-title":"Crit. Care Med."},{"key":"78901_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00134-022-06898-5","volume":"49","author":"I Martin-Loeches","year":"2023","unstructured":"Martin-Loeches, I., Chastre, J. & Wunderink, R. G. Bronchoscopy for diagnosis of ventilator-associated pneumonia. Intensive Care Med 49, 79\u201382 (2023).","journal-title":"Intensive Care Med"},{"key":"78901_CR21","doi-asserted-by":"publisher","unstructured":"Asis, A. et al. The double threat: bacterial and fungal co-\/superinfection in viral pneumonia. Expert Rev. Respir. Med. 20, 847\u2013858 https:\/\/doi.org\/10.1080\/17476348.2026.2629003 (2026).","DOI":"10.1080\/17476348.2026.2629003"},{"key":"78901_CR22","doi-asserted-by":"publisher","unstructured":"Bustos, I. G., Martinez-Lemus, L. F., Reyes, L. F. & Martin-Loeches, I. Transforming microbiological diagnostics in nosocomial lower respiratory tract infections: innovations shaping the future. Diagnostics 15, 265 https:\/\/doi.org\/10.3390\/diagnostics15030265 (2025).","DOI":"10.3390\/diagnostics15030265"},{"key":"78901_CR23","doi-asserted-by":"publisher","unstructured":"De Pascale, G. et al. Intensive care unit patients with lower respiratory tract nosocomial infections: the ENIRRIs project. ERJ Open Res. 3, 00092-2017 https:\/\/doi.org\/10.1183\/23120541.00092-2017 (2017).","DOI":"10.1183\/23120541.00092-2017"},{"key":"78901_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03219-4","volume":"24","author":"I Martin-Loeches","year":"2020","unstructured":"Martin-Loeches, I. et al. The importance of airway and lung microbiome in the critically ill. Crit. Care 24, 537 (2020).","journal-title":"Crit. Care"},{"key":"78901_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52713-8","volume":"15","author":"M Cheng","year":"2024","unstructured":"Cheng, M. et al. Deep longitudinal lower respiratory tract microbiome profiling reveals genome-resolved functional and evolutionary dynamics in critical illness. Nat. Commun. 15, 8361 (2024).","journal-title":"Nat. Commun."},{"key":"78901_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12931-025-03485-2","volume":"27","author":"GG Einarsson","year":"2026","unstructured":"Einarsson, G. G. et al. Biofilm communities above and below the cuff of endotracheal tubes are spatially homogenous. Respir. Res. 27, 74 (2026).","journal-title":"Respir. Res."},{"key":"78901_CR27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1164\/rccm.201907-1487OC","volume":"201","author":"RP Dickson","year":"2020","unstructured":"Dickson, R. P. et al. Lung microbiota predict clinical outcomes in critically ill patients. Am. J. Respir. Crit. Care Med. 201, 555\u2013563 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"78901_CR28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2478\/jccm-2018-0011","volume":"4","author":"O Diaconu","year":"2018","unstructured":"Diaconu, O., Siriopol, I., Polo\u0219anu, L. I. & Grigora\u0219, I. Endotracheal tube biofilm and its impact on the pathogenesis of ventilator-associated pneumonia. J. Crit. Care Med. 4, 50\u201355 (2018).","journal-title":"J. Crit. Care Med."},{"key":"78901_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s44158-023-00095-6","volume":"3","author":"A Cortegiani","year":"2023","unstructured":"Cortegiani, A. et al. Rationale and clinical application of antimicrobial stewardship principles in the intensive care unit: a multidisciplinary statement. J. Anesth. Analg. Crit. Care 3, 11 (2023).","journal-title":"J. Anesth. Analg. Crit. Care"},{"key":"78901_CR30","doi-asserted-by":"crossref","first-page":"155306","DOI":"10.1016\/j.jcrc.2025.155306","volume":"91","author":"I Martin-Loeches","year":"2026","unstructured":"Martin-Loeches, I., Torres, A. & Roquilly, A. Hospital-acquired pneumonia: past, present, and perspectives. J. Crit. Care 91, 155306 (2026).","journal-title":"J. Crit. Care"},{"key":"78901_CR31","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1017\/ice.2022.88","volume":"43","author":"M Klompas","year":"2022","unstructured":"Klompas, M. et al. Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 update. Infect. Control Hosp. Epidemiol. 43, 687\u2013713 (2022).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"78901_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-021-00976-5","volume":"12","author":"P Szychowiak","year":"2022","unstructured":"Szychowiak, P., Villageois-Tran, K., Patrier, J., Timsit, J. F. & Rupp\u00e9, \u00c9 The role of the microbiota in the management of intensive care patients. Ann. Intensive Care 12, 3 (2022).","journal-title":"Ann. Intensive Care"},{"key":"78901_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01610-1","volume":"11","author":"S Fredriksen","year":"2023","unstructured":"Fredriksen, S., de Warle, S., van Baarlen, P., Boekhorst, J. & Wells, J. M. Resistome expansion in disease-associated human gut microbiomes. Microbiome 11, 166 (2023).","journal-title":"Microbiome"},{"key":"78901_CR34","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s00134-020-05980-0","volume":"46","author":"L Papazian","year":"2020","unstructured":"Papazian, L., Klompas, M. & Luyt, C.-E. Ventilator-associated pneumonia in adults: a narrative review. Intensive Care Med. 46, 888\u2013906 (2020).","journal-title":"Intensive Care Med."},{"key":"78901_CR35","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1007\/s00134-020-06036-z","volume":"46","author":"SM Fernando","year":"2020","unstructured":"Fernando, S. M. et al. Diagnosis of ventilator-associated pneumonia in critically ill adult patients, a systematic review and meta-analysis. Intensive Care Med. 46, 1170\u20131179 (2020).","journal-title":"Intensive Care Med."},{"key":"78901_CR36","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/00000542-199604000-00002","volume":"84","author":"N F\u00e0bregas","year":"1996","unstructured":"F\u00e0bregas, N. et al. Histopathologic and microbiologic aspects of ventilator-associated pneumonia. Anesthesiology 84, 760\u2013771 (1996).","journal-title":"Anesthesiology"},{"key":"78901_CR37","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1097\/CCM.0b013e3182a262db","volume":"41","author":"SS Magill","year":"2013","unstructured":"Magill, S. S. et al. Developing a new, national approach to surveillance for ventilator-associated events. Crit. Care Med. 41, 2467\u20132475 (2013).","journal-title":"Crit. Care Med."},{"key":"78901_CR38","unstructured":"Centers for Disease Control and Prevention. Ventilator-Associated Event (VAE) Protocol. National Healthcare Safety Network (NHSN) Patient Safety Component Manual. https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/10-vae_final.pdf (accessed 3 July 2026)."},{"key":"78901_CR39","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jointm.2022.09.004","volume":"3","author":"S Ramirez-Estrada","year":"2023","unstructured":"Ramirez-Estrada, S., Pe\u00f1a-Lopez, Y., Vieceli, T. & Rello, J. Ventilator-associated events: from surveillance to optimizing management. J. Intensive Med. 3, 204\u2013211 (2023).","journal-title":"J. Intensive Med."},{"key":"78901_CR40","first-page":"e23634","volume":"14","author":"H Shah","year":"2022","unstructured":"Shah, H. et al. Trends and factors associated with ventilator-associated pneumonia: a national perspective. Cureus 14, e23634 (2022).","journal-title":"Cureus"},{"key":"78901_CR41","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s40121-023-00820-2","volume":"12","author":"A Alnimr","year":"2023","unstructured":"Alnimr, A. Antimicrobial resistance in ventilator-associated pneumonia: predictive microbiology and evidence-based therapy. Infect. Dis. Ther. 12, 1527\u20131552 (2023).","journal-title":"Infect. Dis. Ther."},{"key":"78901_CR42","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1378\/chest.101.2.458","volume":"101","author":"RG Wunderink","year":"1992","unstructured":"Wunderink, R. G. et al. The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia. Chest 101, 458\u2013463 (1992).","journal-title":"Chest"},{"key":"78901_CR43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.aucc.2023.08.002","volume":"37","author":"LJ Churchill","year":"2024","unstructured":"Churchill, L. J., Tronstad, O., Mandrusiak, A. M., Waldmann, J. Y. & Thomas, P. J. The role of lung ultrasound for detecting atelectasis, consolidation, and\/or pneumonia in the adult cardiac surgery population: a scoping review of the literature. Aust. Crit. Care 37, 193\u2013201 (2024).","journal-title":"Aust. Crit. Care"},{"key":"78901_CR44","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.chest.2015.12.012","volume":"149","author":"S Mongodi","year":"2016","unstructured":"Mongodi, S. et al. Lung ultrasound for early diagnosis of ventilator-associated pneumonia. Chest 149, 969\u2013980 (2016).","journal-title":"Chest"},{"key":"78901_CR45","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1007\/s00134-025-07932-y","volume":"51","author":"S Mongodi","year":"2025","unstructured":"Mongodi, S. et al. ESICM-ESPNIC international expert consensus on quantitative lung ultrasound in intensive care. Intensive Care Med. 51, 1022\u20131049 (2025).","journal-title":"Intensive Care Med."},{"key":"78901_CR46","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/imr.12499","volume":"274","author":"MJ Delano","year":"2016","unstructured":"Delano, M. J. & Ward, P. A. The immune system\u2019s role in sepsis progression, resolution, and long-term outcome. Immunol. Rev. 274, 330\u2013353 (2016).","journal-title":"Immunol. Rev."},{"key":"78901_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-025-05623-0","volume":"29","author":"Y de Albuquerque Pessoa Dos Santos","year":"2025","unstructured":"de Albuquerque Pessoa Dos Santos, Y. et al. Impact of syndromic molecular diagnostics on antimicrobial adequacy and time to therapy in critically ill patients with pneumonia: a systematic review and meta-analysis of randomized trials. Crit. Care 29, 379 (2025).","journal-title":"Crit. Care"},{"key":"78901_CR48","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/19433654261427734","volume":"71","author":"K Vaporidi","year":"2026","unstructured":"Vaporidi, K., Andrianakis, E. & Bolaki, M. Understanding the control of breathing to optimize patient-ventilator interactions. Respir. Care 71, 547\u2013565 (2026).","journal-title":"Respir. Care"},{"key":"78901_CR49","doi-asserted-by":"crossref","first-page":"100712","DOI":"10.1016\/j.microb.2026.100712","volume":"11","author":"S Asokan","year":"2026","unstructured":"Asokan, S. et al. Biofilm associated infections on medical devices: pathogenesis, diagnostic challenges, and control strategies. Microbe 11, 100712 (2026).","journal-title":"Microbe"},{"key":"78901_CR50","doi-asserted-by":"publisher","unstructured":"Manzari, C. et al. Accurate quantification of bacterial abundance in metagenomic DNAs accounting for variable DNA integrity levels. Microb. Genom. 6, 000417 https:\/\/doi.org\/10.1099\/mgen.0.000417 (2020).","DOI":"10.1099\/mgen.0.000417"},{"key":"78901_CR51","doi-asserted-by":"crossref","first-page":"142431","DOI":"10.1016\/j.jhazmat.2026.142431","volume":"513","author":"A Majumdar","year":"2026","unstructured":"Majumdar, A., Bagchi, D., Kotta-Loizou, I. & Buck, M. The One Health resistome: integrating environmental, microbial, and human antimicrobial resistance surveillance and risk analysis in the digital age. J. Hazard. Mater. 513, 142431 (2026).","journal-title":"J. Hazard. Mater."},{"key":"78901_CR52","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez-G\u00f3mez, M. et al. RAPID-CARE: rapid antibiotic optimization in the ICU after implementation of a pneumonia multiplex PCR test, a real-world evaluation. Antibiotics 14, 1084 https:\/\/doi.org\/10.3390\/antibiotics14111084 (2025).","DOI":"10.3390\/antibiotics14111084"},{"key":"78901_CR53","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12890-021-01560-0","volume":"21","author":"B Al-Omari","year":"2021","unstructured":"Al-Omari, B. et al. Systematic review of studies investigating ventilator associated pneumonia diagnostics in intensive care. BMC Pulm. Med. 21, 196 (2021).","journal-title":"BMC Pulm. Med."},{"key":"78901_CR54","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S2213-2600(22)00086-8","volume":"10","author":"AM Darie","year":"2022","unstructured":"Darie, A. M. et al. Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial. Lancet Respir. Med. 10, 877\u2013887 (2022).","journal-title":"Lancet Respir. Med."},{"key":"78901_CR55","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/5584_2020_591","volume":"1323","author":"F Alessandri","year":"2021","unstructured":"Alessandri, F. et al. Procalcitonin in the assessment of ventilator associated pneumonia: a systematic review. Adv. Exp. Med. Biol. 1323, 103\u2013114 (2021).","journal-title":"Adv. Exp. Med. Biol."},{"key":"78901_CR56","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.ijantimicag.2015.10.012","volume":"46","author":"N Br\u00e9chot","year":"2015","unstructured":"Br\u00e9chot, N., H\u00e9kimian, G., Chastre, J. & Luyt, C.-E. Procalcitonin to guide antibiotic therapy in the ICU. Int. J. Antimicrob. Agents 46, S19\u2013S24 (2015).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"78901_CR57","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jcrc.2018.09.036","volume":"48","author":"L Coelho","year":"2018","unstructured":"Coelho, L. et al. C-reactive protein and procalcitonin profile in ventilator-associated lower respiratory infections. J. Crit. Care 48, 385\u2013389 (2018).","journal-title":"J. Crit. Care"},{"key":"78901_CR58","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jama.2024.26458","volume":"333","author":"P Dark","year":"2025","unstructured":"Dark, P. et al. Biomarker-guided antibiotic duration for hospitalized patients with suspected sepsis: the ADAPT-Sepsis randomized clinical trial. JAMA 333, 682\u2013693 (2025).","journal-title":"JAMA"},{"key":"78901_CR59","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/14787210.2021.1857730","volume":"19","author":"I Martin-Loeches","year":"2021","unstructured":"Martin-Loeches, I., Metersky, M., Kalil, A., Pezzani, M. D. & Torres, A. Strategies for implementation of a multidisciplinary approach to the treatment of nosocomial infections in critically ill patients. Expert Rev. Anti Infect. Ther. 19, 759\u2013767 (2021).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"78901_CR60","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S2213-2600(23)00330-2","volume":"12","author":"S Cajander","year":"2024","unstructured":"Cajander, S. et al. Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine. Lancet Respir. Med. 12, 305\u2013322 (2024).","journal-title":"Lancet Respir. Med."},{"key":"78901_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3195-5","volume":"18","author":"X Li","year":"2018","unstructured":"Li, X. et al. Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis. BMC Infect. Dis. 18, 289 (2018).","journal-title":"BMC Infect. Dis."},{"key":"78901_CR62","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.antiviral.2011.03.179","volume":"90","author":"CH Cook","year":"2011","unstructured":"Cook, C. H. & Trgovcich, J. Cytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges. Antivir. Res. 90, 151\u2013159 (2011).","journal-title":"Antivir. Res."},{"key":"78901_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/cc11922","volume":"17","author":"R Almansa","year":"2013","unstructured":"Almansa, R. et al. Immunological monitoring to prevent and treat sepsis. Crit. Care 17, 109 (2013).","journal-title":"Crit. Care"},{"key":"78901_CR64","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1038\/s41591-025-03956-5","volume":"31","author":"AR Moore","year":"2025","unstructured":"Moore, A. R. et al. A consensus immune dysregulation framework for sepsis and critical illnesses. Nat. Med. 31, 4084\u20134096 (2025).","journal-title":"Nat. Med."},{"key":"78901_CR65","doi-asserted-by":"crossref","first-page":"1498974","DOI":"10.3389\/fimmu.2024.1498974","volume":"15","author":"A Samuelsen","year":"2024","unstructured":"Samuelsen, A., Lehman, E., Burrows, P. & Bonavia, A. S. Time-dependent variation in immunoparalysis biomarkers among patients with sepsis and critical illness. Front. Immunol. 15, 1498974 (2024).","journal-title":"Front. Immunol."},{"key":"78901_CR66","doi-asserted-by":"crossref","first-page":"154137","DOI":"10.1016\/j.jcrc.2022.154137","volume":"72","author":"A Borouchaki","year":"2022","unstructured":"Borouchaki, A., de Roquetaillade, C., Barth\u00e9l\u00e9my, R., Mebazaa, A. & Chousterman, B. G. Immunotherapy to treat sepsis induced-immunosuppression: immune eligibility or outcome criteria, a systematic review. J. Crit. Care 72, 154137 (2022).","journal-title":"J. Crit. Care"},{"key":"78901_CR67","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/s41590-020-0673-x","volume":"21","author":"A Roquilly","year":"2020","unstructured":"Roquilly, A. et al. Alveolar macrophages are epigenetically altered after inflammation, leading to long-term lung immunoparalysis. Nat. Immunol. 21, 636\u2013648 (2020).","journal-title":"Nat. Immunol."},{"key":"78901_CR68","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1164\/ajrccm.157.2.9705064","volume":"157","author":"JL Trouillet","year":"1998","unstructured":"Trouillet, J. L. et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am. J. Respir. Crit. Care Med. 157, 531\u2013539 (1998).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"78901_CR69","doi-asserted-by":"crossref","DOI":"10.1016\/j.aicoj.2026.100085","volume":"16","author":"LS Boers","year":"2026","unstructured":"Boers, L. S. et al. Alveolar dysregulation of host response in pneumonia and ARDS: implications for immune modulation and infection. Ann. Intensive Care 16, 100085 (2026).","journal-title":"Ann. Intensive Care"},{"key":"78901_CR70","doi-asserted-by":"crossref","first-page":"E12353","DOI":"10.1073\/pnas.1809700115","volume":"115","author":"C Langelier","year":"2018","unstructured":"Langelier, C. et al. Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults. Proc. Natl. Acad. Sci. USA 115, E12353\u2013E12362 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"78901_CR71","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss, R. S., Monneret, G. & Payen, D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13, 862\u2013874 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"78901_CR72","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3390\/antibiotics13020162","volume":"13","author":"R Cusack","year":"2024","unstructured":"Cusack, R., Little, E. & Martin-Loeches, I. Practical lessons on antimicrobial therapy for critically ill patients. Antibiotics 13, 162 (2024).","journal-title":"Antibiotics"},{"key":"78901_CR73","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1473-3099(16)00065-7","volume":"16","author":"EC Schuts","year":"2016","unstructured":"Schuts, E. C. et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect. Dis. 16, 847\u2013856 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"78901_CR74","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.cmi.2025.03.013","volume":"31","author":"A Oliver","year":"2025","unstructured":"Oliver, A., Arca-Su\u00e1rez, J., Gomis-Font, M. A., Gonz\u00e1lez-Pinto, L. & L\u00f3pez-Causap\u00e9, C. Emerging resistance mechanisms to newer \u03b2-lactams in Pseudomonas aeruginosa. Clin. Microbiol. Infect. 31, 1790\u20131796 (2025).","journal-title":"Clin. Microbiol. Infect."},{"key":"78901_CR75","doi-asserted-by":"publisher","unstructured":"Tamma, P. D. et al. Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciae403ciae403 (2024).","DOI":"10.1093\/cid\/ciae403ciae403"},{"key":"78901_CR76","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","volume":"28","author":"M Paul","year":"2022","unstructured":"Paul, M. et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli. Clin. Microbiol. Infect. 28, 521\u2013547 (2022).","journal-title":"Clin. Microbiol. Infect."},{"key":"78901_CR77","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/14787210.2022.1999804","volume":"20","author":"A Garduno","year":"2022","unstructured":"Garduno, A. & Mart\u00edn-Loeches, I. Efficacy and appropriateness of novel antibiotics in response to antimicrobial-resistant gram-negative bacteria in patients with sepsis in the ICU. Expert Rev. Anti Infect. Ther. 20, 513\u2013531 (2022).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"78901_CR78","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-0041-1742105","volume":"43","author":"YP Abouelhassan","year":"2022","unstructured":"Abouelhassan, Y. P. & Nicolau, D. P. Pharmacokinetic\/pharmacodynamic optimization of hospital-acquired and ventilator-associated pneumonia: challenges and strategies. Semin. Respir. Crit. Care Med. 43, 175\u2013182 (2022).","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"78901_CR79","doi-asserted-by":"crossref","unstructured":"Guilhaumou, R. et al. \u03b2-Lactam pharmacokinetic\/pharmacodynamic target attainment in intensive care unit patients: a prospective, observational, cohort study. Antibiotics. 12 (2023).","DOI":"10.3390\/antibiotics12081289"},{"key":"78901_CR80","first-page":"516","volume":"20","author":"I Mart\u00edn-Loeches","year":"2014","unstructured":"Mart\u00edn-Loeches, I., Diaz, E. & Vall\u00e9s, J. Risks for multidrug-resistant pathogens in the ICU. Curr. Opin. Crit. Care 20, 516\u2013524 (2014).","journal-title":"Curr. Opin. Crit. Care"},{"key":"78901_CR81","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/QCO.0000000000000491","volume":"31","author":"JJ De Waele","year":"2018","unstructured":"De Waele, J. J. & Martin-Loeches, I. Optimal duration of antibiotic treatment in Gram-negative infections. Curr. Opin. Infect. Dis. 31, 606\u2013611 (2018).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"78901_CR82","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00050-19","volume":"34","author":"F Baquero","year":"2021","unstructured":"Baquero, F. et al. Evolutionary pathways and trajectories in antibiotic resistance. Clin. Microbiol. Rev. 34, e0005019 (2021).","journal-title":"Clin. Microbiol. Rev."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-78901-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-78901-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-78901-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:56:44Z","timestamp":1792195004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-78901-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["78901"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-78901-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"10 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I.M.-L. reports research grants or institutional support from Gilead, MSD and Pfizer; consulting fees from Gilead and MSD; lecture honoraria from MSD, Gilead and Mundipharma; and advisory-board or lecture activity for Pfizer, MSD and Menarini, all outside the submitted work. A.T. reports consulting fees, lecture honoraria or advisory-board activity from Pfizer, MSD and Menarini, all outside the submitted work. The authors declare no other financial or non-financial competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10875"}}